Smart system helps nurses and doctors stop dangerous low blood sugar in its tracks

NCT ID NCT07314749

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a team of doctors and nurses, guided by an intelligent early-warning system, could reduce low blood sugar (hypoglycemia) in hospitalized adults with type 2 diabetes. Over 1,200 participants received either standard insulin pump therapy or the same therapy plus the collaborative intervention, which included personalized insulin adjustments and risk-based education. The goal was to see if the smart system could help prevent hypoglycemia and help patients reach their blood sugar targets faster.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Physician-nurse collaborative intervention guided by an intelligent hypoglycemia risk early-warning system
What this could lead to
If successful, this approach could help hospitals prevent dangerous low blood sugar episodes and help patients with type 2 diabetes reach their blood sugar targets faster during insulin pump therapy.
What could go wrong
This is a completed study, but its findings may not apply to all diabetes patients, especially those not hospitalized or on different treatments. The intelligent system's accuracy and generalizability need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Third Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510630, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.